Institutional Ownership
Lifecore Biomedical Inc
CUSIP 514766104COMLFCRQ1 2026
13D / 13G Filings
60
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
15.4%
Max % of class reported
Institutional Holders
101
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
60 filings · latest Jan 21, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.1% | 1.90M | SEC |
| 2 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 4.9% | 1.83M | SEC |
| 3 | Jul 17, 2025 | Blackrock, Inc. | 13G | 5.0% | 1.87M | SEC |
| 4 | May 29, 2025 | 22nw Fund, LP | 13D/A | 7.5% | — | SEC |
| 5 | Feb 14, 2025 | Greenhaven Road Investment Management, L.P. | 13G/A | 9.8% | 9.23B | SEC |
| 6 | Feb 14, 2025 | Greenhaven Road Investment Management, L.P. | 13G/A | 7.8% | 9.23B | SEC |
| 7 | Feb 5, 2025 | David Capital Partners, LLC | 13G/A | 4.9% | 1.80M | SEC |
| 8 | Dec 26, 2024 | 22nw Fund, LP | 13D/A | 11.1% | — | SEC |
| 9 | Nov 12, 2024 | David Capital Partners, LLC | 13G | 5.4% | 1.66M | SEC |
| 10 | Oct 7, 2024 | Legion Partners Asset Management, LLC | 13D/A | 15.4% | 5.94M | SEC |
50 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Lifecore Biomedical Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | 22nw, LP | 1.3K | $18.87M |
| 2 | Wynnefield Capital Inc | 4.70M | $17.50M |
| 3 | Legion Partners Asset Management, LLC | 4.46M | $16.60M |
| 4 | Greenhaven Road Investment Management, L.P. | 3.54M | $13.16M |
| 5 | 325 Capital LLC | 2.16M | $8.04M |
| 6 | Blackrock, Inc. | 1.88M | $6.98M |
| 7 | Grizzlyrock Capital, LLC | 827.5K | $3.08M |
| 8 | Geode Capital Management, LLC | 815.1K | $3.03M |
| 9 | Morgan Stanley | 764.7K | $2.84M |
| 10 | State Street Corp | 642.0K | $2.39M |